You were just another C.T.R.L. employee clocking the graveyard shift, filing reports on things that shouldn’t exist. Now, the facility is under a sudden, total lockdown. Your main objective? Survive ...

Richard Smith lost his left leg to diabetes a year ago and is starting to feel loss of sensation in his other leg. At age 72, the retired maintenance worker kept ending up on the floor in his ...

Novartis’ groundbreaking cancer T-cell therapy CTL019 has won unanimous backing from advisers to the FDA, paving the way for approval in the coming months. There had been concerns that the expert ...

Symposium exploring innovations in synthesis, production, and application potential of graphene and other 2D materials. Format: In person; part of TechConnect World Innovation Conference with posters ...